Carregant...
The Impact of COVID-19 on the Conduct of Clinical Trials for Medical Products in Korea
BACKGROUND: The number of clinical trials conducted in Korea continues to increase and an increasing proportion focus on severe and rare incurable diseases. After the start of the severe acute respiratory syndrome, coronavirus disease 2019 (COVID-19), Korea Centers for Disease Control and Prevention...
Guardat en:
| Publicat a: | J Korean Med Sci |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The Korean Academy of Medical Sciences
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7490200/ https://ncbi.nlm.nih.gov/pubmed/32924344 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2020.35.e329 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|